HSBC Holdings’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,896
| Closed | -$780K | – | 2645 |
|
|
2024
Q4 | $780K | Buy |
+31,896
| New | +$780K | ﹤0.01% | 1564 |
|
|
2024
Q2 | – | Sell |
-7,298
| Closed | -$236K | – | 2625 |
|
|
2024
Q1 | $236K | Buy |
+7,298
| New | +$236K | ﹤0.01% | 2187 |
|
|
2023
Q1 | – | Sell |
-49,592
| Closed | -$862K | – | 2349 |
|
|
2022
Q4 | $862K | Sell |
49,592
-79,697
| -62% | -$1.39M | ﹤0.01% | 1638 |
|
|
2022
Q3 | $712K | Buy |
129,289
+6,869
| +6% | +$37.8K | ﹤0.01% | 1609 |
|
|
2022
Q2 | $486K | Buy |
122,420
+12,481
| +11% | +$49.5K | ﹤0.01% | 1966 |
|
|
2022
Q1 | $615K | Buy |
109,939
+4,866
| +5% | +$27.2K | ﹤0.01% | 1926 |
|
|
2021
Q4 | $909K | Buy |
105,073
+47,785
| +83% | +$413K | ﹤0.01% | 1691 |
|
|
2021
Q3 | $510K | Buy |
+57,288
| New | +$510K | ﹤0.01% | 1805 |
|
|
2021
Q1 | – | Sell |
-7,899
| Closed | -$366K | – | 2462 |
|
|
2020
Q4 | $366K | Sell |
7,899
-5,221
| -40% | -$242K | ﹤0.01% | 2012 |
|
|
2020
Q3 | $481K | Sell |
13,120
-12,153
| -48% | -$446K | ﹤0.01% | 1578 |
|
|
2020
Q2 | $615K | Sell |
25,273
-3,469
| -12% | -$84.4K | ﹤0.01% | 1367 |
|
|
2020
Q1 | $447K | Buy |
+28,742
| New | +$447K | ﹤0.01% | 1446 |
|